Upon invading amoeba and human cells, L. pneumophila evades the endosomal-lysosomal degradation pathway by entering a vacuole, designated the Legionella-containing vacuole (LCV) (Fig. 1) . The LCV intercepts endoplasmic reticulum (ER)-to-Golgi vesicular traffıc, and becomes quickly remodeled into an ER-derived vacuole (Fig. 1) . L. pneumophila rapidly replicates in the LCV to a high density but, prior to egress, the bacteria escape into the cytosol for another 1-2 rounds of proliferation (Fig. 1) .
People who inhale Legionella-contaminated aerosols can become infected when the bacteria invade and replicate within alveolar macrophages, using mechanisms that also operate SUMMARY ➤ When Legionella pneumophila, which causes Legionnaires' disease, infects humans or amoeba, the bacteria promote host proteasomal degradation to obtain amino acids for growth.
➤ The Dot/Icm type IV secretion apparatus of L. pneumophila injects host cells with about 300 different effector proteins, close to 10% of its genomic coding capacity.
➤ When Legionella enters an intracellular vacuole, called the LCV, it is soon decorated with polyubiquitinated proteins, a process that depends on the AnkB Dot/Icm-translocated effector being anchored into the LCV membrane.
➤ Proteasome-mediated degradation of such polyubiquitinated proteins generates amino acids needed to power replication of L. pneumophila.
➤ By synchronizing amino acid auxotrophy with its amoeba hosts, L. pneumophila may be protected within starved amoebic cysts until nutrients are again abundant. Infectious extracellular L. pneumophila attach to and are engulfed by eukaryotic cells, and then translocates many effector proteins through its Dot/Icm type IV secretion system to divert its vacuole away from the default endocytic pathway (1). The Legionella-containing vacuole (LCV) matures into a rough ER-like vacuole and also associates with mitochondria (2). During exponential growth, the bacteria are non-flagellated (3). Later, the bacteria escape into the cytosol for 1-2 final rounds of proliferation, during which amino acids and fatty acid supplies are exhausted, triggering RelA and SpoT to synthesize ppGpp and signaling L. pneumophila to revert to its flagellated form (4). These L. pneumophila depart the host cell for the extracellular environment (5).
increased infectivity. This dramatic phenotypic switch occurs after amino acid and fatty acids supplies are exhausted, triggering RelA and SpoT to synthesize the bacterial alarmone ppGpp, which is a master regulator of numerous genes required for Legionella pathogenesis.
Before that switch, L. pneumophila cells replicate with a generation time of about 40 minutes, devouring tremendous amounts of carbon and nitrogen for energy and biomass. Early efforts to develop a suitable culture medium for L. pneumophila recognized that this organism relies on amino acids, particularly serine, for energy, with little to no use for carbohydrates. Thus, L. pneumophila is routinely cultured on buffered charcoal yeast extract (BCYE) agar with a supplement of 3 mM cysteine, whose basis was unraveled recently. This organism is auxotrophic not only for cysteine but also arginine, isoleucine, leucine, methionine, valine, and threonine. Moreover, its glycolytic pathway is incomplete but the tricarboxylic acid (TCA) cycle is intact. Serine is directly metabolized to pyruvate to feed the TCA cycle, and genetic evidence suggests cysteine and other amino acids also feed the TCA cycle.
Elaborate Legionella Strategy for Meeting Nutrient Needs
How does L. pneumophila meet its nutritional needs for amino acids in amoeba and mammalian host cells? Within few minutes of forming the LCV in amoeba and human cells, it becomes decorated with polyubiquitinated proteins (Fig. 2C) , a process that depends on the AnkB Dot/Icmtranslocated effector being anchored into the LCV membrane. The AnkB protein is found in 211 of 217 tested strains. It is composed of several eukaryotic-like domains, including an F-box, two ankyrin domains, and a C-terminal CaaX prenylation motif (Fig. 2) .
Prenylation is a highly conserved eukaryotic posttranslational modifıcation that covalently links a 15-carbon farnesyl or 20-carbon geranylgeranyl lipid moiety to a cysteine residue at the -4 position from the C-terminus of a protein, increasing hydrophobicity and enabling the lipidated protein to be anchored into membranes (Fig. 3A) . When farnesylated, AnkB attaches to the outer leaflets of LCV membranes within amoeba and human cells. The LCV is the only pathogen-containing vacuole known to hijack the highly conserved host farnesylation enzymatic machinery, which is recruited by Legionella to the LCV membrane.
Another highly conserved eukaryotic posttranslational process hijacked by AnkB is ubiquitination. This process covalently tags proteins with repeating units of the 76-amino acid polypeptide called ubiquitin, and it involves three enzymes, E1, E2, and E3 (Fig. 3B) . Eukaryotic F-box proteins interact with the E3 SCF1 (SKP1/CUL1/ F-box) ubiquitin ligase complex to modify protein targets with a ubiquitin monomer or polymer (Fig. 3B) . The F-box domain binds the E3 ubiquitin ligase, while the ubiquitination target protein binds the F-box protein through a protein-protein interaction repeat domain, such as LRR or WD 40 in higher eukaryotes, or Ankyrin repeats in unicellular eukaryotes such as amoebae.
Findings from Ralph Isberg's lab at Tufts University in Boston, Mass., have shown the LCV to be decorated with polyubiquitinated proteins, but the molecular bases of this were not known. Simultaneous and independent work from Carmen Buchrieser's lab at the Institut Pasteur in Paris and by our lab have shown the AnkB F-box effector of two distinct clinical isolates to be directly responsible for this decoration of the LCV. Through molecular and biochemical mimicry, AnkB functions on the LCV membrane within amoeba and mammalian cells as a bona fıde eukaryotic F-box protein that interacts with the host SCF1 ubiquitin ligase complex (Fig. 4A) .
Polyubiquitination of proteins plays a key role in their fate, including degradation, cellular localization, and functional modifıcation, and this fate depends on the linkage pattern between the ubiquitin monomers in the polyubiquitin polymer. Ubiquitin monomers are covalently linked through any of the seven lysine (K) residues of ubiquitin. Proteins tagged with a K48-linked polyubiquitin chain are destined for degradation via the proteasome, a large, multisubunit proteolytic complex that yields short peptides (ϳ8 amino acids), which cytosolic peptidases hydrolyze to amino acids (Fig 3B) .
Intricacies of L. pneumophila Revealed by the ankB Mutant
Although the ankB mutant of L. pneumophila is severely defective in intracellular proliferation in amoeba and human cells, it evades lysosomal fusion and forms the ER-remodeled LCVs similar to the wild-type strain (Fig. 1) . However, while the LCV harboring the wild-type strain is preferentially decorated with K48-linked polyubiquitinated proteins, a process essential for intracellular proliferation, polyubiquitinated proteins do not decorate LCVs containing the ankB mutant within amoeba and human cells.
These results led us to ask why decorating the LCV with K48-linked polyubiquitinated proteins enables L. pneumophila to proliferate. Perhaps AnkB targets particular host proteins or L. pneumophila effectors for proteasome-mediated degradation. Alternatively, the higher levels of cellular amino acids generated through proteasome-mediated degradation of polyubiquitinated proteins is needed to power intracellular replication of L. pneumophila.
Several fındings lend support to this second possibility, including: (i) the ankB mutant exhibits an amino acid starvation response; (ii) substituting arginine for K48 of ubiquitin abolishes LCV decoration, induces an amino acid starvation response, and blocks intracellular proliferation of the wild-type strain; (iii) host proteasome and cytosolic peptidase activities are required for replication of the wild-type strain; and (iv) after L. pneumophila infects cells, levels of cellular amino acids rise dramatically, and this rise is totally dependent on AnkB.
Therefore, our simple approach was to examine if we can rescue the ankB mutant by providing amoeba and human cells with excess amino acids to make up for the defect of AnkB-dependent rise in cellular amino acids. Intriguingly, adding amino acids reverses the intracellular growth defect of the ankB mutant and also restores growth of wild-type L. pneumophila in human cells overexpressing the K48-R ubiquitin variant or in cells in which proteasomal degradation or cytosolic peptidases are inhibited. Moreover, adding certain single amino acids, such as cysteine or serine, also can restore intracellular growth of the ankB mutant in amoeba and human cells. This result reflects the fact that L. pneumophila metabolizes these amino acids to feed the TCA cycle, where they are converted into pyruvate and then acetyl CoA (Fig. 4) . Recent studies from Anne Bertolotti's lab at the MRC labs of Molecular Biology in Cambridge, UK, have shown that inhibition of proteasomal protein degradation in yeast, mammals, and flies leads to cell death due to depletion of cellular amino acids. The lethality of amino acid depletion upon inhibition of the proteasomes is reversed by supplementation of cysteine, which is the least abundant cellular amino acid. Thus, Legionella hijacks a major cellular protein degradation pathway essential for generating amino acids, and cysteine in particular, in all eukaryotes.
This case is the fırst of its kind in which a translocated effector manipulates several host pathways, but the ultimate goal of these manipulations is to generate carbon and energy needed for intracellular bacterial growth. AnkB not only links cellular microbiology and virulence of L. pneumophila to its metabolism, it also exploits eukaryotic farnesylation, polyubiquitination, and proteasomal degradation machineries that are conserved throughout the eukaryotic kingdom.
Advantages of Hijacking Host Metabolic Processes
What is the advantage of hijacking host proteasome machinery to generate food sources-particularly for an accidental pathogen? To survive in waterways, L. pneumophila invades amoeba, ciliates, and possibly other eukaryotes. Unable to make cysteine, L. pneumophila targets this highly conserved proteolytic complex to generate higher levels of cellular amino acids and cysteine in particular, improving survival chances in whatever eukaryote it invades, ranging from unicellular amoebae to humans.
Acanthamoebae, a primary aquatic host of L. pneumophila, are auxotrophic for several amino acids, including cysteine (Fig. 4C) . Another host, the social amoeba Dictyostelium discoideum, is auxotrophic for 11 amino acids, including cysteine, while cysteine is semi-essential in humans. Why did Legionella evolve to be so dependent on cysteine, which is essential for the amoeba host? Long-term evolution of L. pneumophila with its amoeba host has resulted in L. pneumophila synchronizing amino acid auxotrophy with the host, a remarkable nutritional adaptation (Fig. 4C) .
We speculate that during times of nutrient abundance for the amoeba host, protein production in the host would be unhindered, and intracellular L. pneumophila can promote host degradation of polyubiquitinated proteins to generate higher levels of cellular amino acids and proliferate. However if key amino acids, such as cysteine, are scarce, amoebae will differentiate into metabolically inactive cysts to survive the starvation conditions, while L. pneumophila would also be starved and no longer replicate within amoebae. In support of this, the ankB mutant bacteria merely wait within the LCV until amino acids become available again.
Thus, by synchronizing amino acid auxotrophy with its host, the bacteria are likely to be protected within an amoeba cyst until nutrients are again abundant. The strict reliance of L. pneumophila on eukaryotic proteasomes for amino acids points to potential water treatment strategies that could reduce the L. pneumophila burden there through inhibiting the amoeba proteasomes.
Since all the functional domains and motifs of AnkB are eukaryotic-like, one wonders where L. pneumophila acquired the ankB gene. It seems likely that L. pneumophila acquired AnkB through interkingdom horizontal gene transfer while intimately associated with primitive unicellular eukaryotes such as amoebae. Indeed, the domain architecture of AnkB of L. pneumophila more closely resembles F-box proteins of unicellular eukaryotes than it does those from mammals. This is evident from the absence of Ankyrin domains in mammalian F-box proteins and their presence in amoeba F-box proteins. It is most likely that adaptation of L. pneumophila to the amoeba host has enabled this bacterium to exploit highly conserved eukaryotic pathways to infect humans. However, the ability of L. pneumophila to modulate other mammalian processes not present in amoeba, such as the inflammasome and pro-and anti-apoptotic pathways, suggests additional long-term adaptation to and interactions of L. pneumophila with other, more complex multicellular eukaryotic hosts. 
